ID   KCC4_HUMAN              Reviewed;         473 AA.
AC   Q16566;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-OCT-2010, entry version 104.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type IV;
DE            Short=CaMK IV;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase-GR;
GN   Name=CAMK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=94375404; PubMed=8089075;
RA   Kitani T., Okuno S., Fujisawa H.;
RT   "cDNA cloning and expression of human calmodulin-dependent protein
RT   kinase IV.";
RL   J. Biochem. 115:637-640(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cerebellum, and Thymus;
RX   MEDLINE=94252566; PubMed=8194751; DOI=10.1016/0378-1119(94)90260-7;
RA   Bland M.M., Monroe R.S., Ohmstede C.A.;
RT   "The cDNA sequence and characterization of the Ca2+/calmodulin-
RT   dependent protein kinase-Gr from human brain and thymus.";
RL   Gene 142:191-197(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   MEDLINE=94149862; PubMed=8107230;
RA   Mosialos G., Hanissian S.H., Jawahar S., Vara L., Kieff E.,
RA   Chatila T.A.;
RT   "A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed
RT   after transformation of primary human B lymphocytes by Epstein-Barr
RT   virus (EBV) is induced by the EBV oncogene LMP1.";
RL   J. Virol. 68:1697-1705(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ENZYME REGULATION, PHOSPHORYLATION AT SER-12; SER-13 AND THR-200, AND
RP   MUTAGENESIS OF SER-12 AND SER-13.
RX   PubMed=8702940; DOI=10.1074/jbc.271.35.21542;
RA   Chatila T., Anderson K.A., Ho N., Means A.R.;
RT   "A unique phosphorylation-dependent mechanism for the activation of
RT   Ca2+/calmodulin-dependent protein kinase type IV/GR.";
RL   J. Biol. Chem. 271:21542-21548(1996).
RN   [6]
RP   FUNCTION IN PHOSPHORYLATION OF STMN1.
RX   PubMed=9154845;
RA   Melander Gradin H., Marklund U., Larsson N., Chatila T.A.,
RA   Gullberg M.;
RT   "Regulation of microtubule dynamics by Ca2+/calmodulin-dependent
RT   kinase IV/Gr-dependent phosphorylation of oncoprotein 18.";
RL   Mol. Cell. Biol. 17:3459-3467(1997).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF MEF2A AND MEF2D.
RX   PubMed=10617605; DOI=10.1074/jbc.275.1.197;
RA   Blaeser F., Ho N., Prywes R., Chatila T.A.;
RT   "Ca(2+)-dependent gene expression mediated by MEF2 transcription
RT   factors.";
RL   J. Biol. Chem. 275:197-209(2000).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=12065094; DOI=10.1016/S0304-3835(02)00107-6;
RA   Takai N., Miyazaki T., Nishida M., Nasu K., Miyakawa I.;
RT   "Ca(2+)/calmodulin-dependent protein kinase IV expression in
RT   epithelial ovarian cancer.";
RL   Cancer Lett. 183:185-193(2002).
RN   [9]
RP   ENZYME REGULATION, INTERACTION WITH SERINE/THREONINE PROTEIN
RP   PHOSPHATASE 2A, PHOSPHORYLATION AT THR-200, AND MUTAGENESIS OF
RP   320-PHE-ASN-321.
RX   PubMed=15143065; DOI=10.1074/jbc.M404523200;
RA   Anderson K.A., Noeldner P.K., Reece K., Wadzinski B.E., Means A.R.;
RT   "Regulation and function of the calcium/calmodulin-dependent protein
RT   kinase IV/protein serine/threonine phosphatase 2A signaling complex.";
RL   J. Biol. Chem. 279:31708-31716(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341 AND SER-360, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356 AND SER-360, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-190, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-150; ASN-178; ARG-465 AND MET-469.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to
CC       a proposed calcium-triggered signaling cascade. May be involved in
CC       transcriptional regulation. May be involved in regulation of
CC       microtubule dynamics. In vitro, phosphorylates CREB1, CREBBP,
CC       PRM2, MEF2A, MEF2D and STMN1/OP18. May be involved in
CC       spermatogenesis. May play a role in the consolidation/retention of
CC       hippocampus-dependent long-term memory (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin may releave intrasteric autoinhibition. Must be
CC       phosphorylated to be maximally active. Phosphorylated by CAMKK1 or
CC       CAMKK2. Autophosphorylation of the N-terminus is required for full
CC       activation. In part, activity is independent on Ca(2+)/calmodulin
CC       and autophosphorylation of Ser-336 allows to switch to a
CC       Ca(2+)/calmodulin-independent state (By similarity). Probably
CC       inactivated by serine/threonine protein phosphatase 2A.
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with serine/threonine
CC       protein phosphatase 2A catalytic subunit, PPP2CA or PPP2CB. The
CC       interaction with PP2CA or PP2CB is mutually exclusive with binding
CC       to Ca(2+)/calmodulin.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Nucleus (By
CC       similarity). Note=Substantial localization in certain neuronal
CC       nuclei. In spermatids associated with chromatin and nuclear matrix
CC       (By similarity).
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial ovarian cancer tissue.
CC   -!- PTM: Autophosphorylated and phosphorylated by CAMKK1 and CAMKK2
CC       (By similarity). Dephosphorylated by serine/threonine protein
CC       phosphatase 2A, probably on Thr-200.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16695.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D30742; BAA06403.1; -; mRNA.
DR   EMBL; L17000; AAA35639.1; -; mRNA.
DR   EMBL; L24959; AAA18251.1; -; mRNA.
DR   EMBL; BC016695; AAH16695.2; ALT_INIT; mRNA.
DR   EMBL; BC025687; AAH25687.1; -; mRNA.
DR   IPI; IPI00430411; -.
DR   PIR; A53036; A53036.
DR   RefSeq; NP_001735.1; -.
DR   UniGene; Hs.591269; -.
DR   PDB; 2W4O; X-ray; 2.17 A; A=15-340.
DR   PDBsum; 2W4O; -.
DR   ProteinModelPortal; Q16566; -.
DR   STRING; Q16566; -.
DR   PhosphoSite; Q16566; -.
DR   PeptideAtlas; Q16566; -.
DR   PRIDE; Q16566; -.
DR   Ensembl; ENST00000282356; ENSP00000282356; ENSG00000152495.
DR   GeneID; 814; -.
DR   KEGG; hsa:814; -.
DR   UCSC; uc003kpf.1; human.
DR   CTD; 814; -.
DR   GeneCards; GC05P110587; -.
DR   H-InvDB; HIX0005080; -.
DR   HGNC; HGNC:1464; CAMK4.
DR   HPA; CAB004347; -.
DR   HPA; HPA011753; -.
DR   HPA; HPA017206; -.
DR   MIM; 114080; gene.
DR   PharmGKB; PA26050; -.
DR   eggNOG; prNOG13858; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q16566; -.
DR   OMA; VHEDEPP; -.
DR   OrthoDB; EOG9N5ZGB; -.
DR   PhylomeDB; Q16566; -.
DR   BRENDA; 2.7.11.17; 247.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Pathway_Interaction_DB; pi3kplctrkpathway; Trk receptor signaling mediated by PI3K and PLC-gamma.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_15295; Opioid Signalling.
DR   NextBio; 3300; -.
DR   PMAP-CutDB; Q16566; -.
DR   ArrayExpress; Q16566; -.
DR   Bgee; Q16566; -.
DR   CleanEx; HS_CAMK4; -.
DR   Genevestigator; Q16566; -.
DR   GermOnline; ENSG00000152495; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR015733; Ca/CaM-dep_prot_kinase4.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF33; CaMKIV; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calcium; Calmodulin-binding;
KW   Complete proteome; Cytoplasm; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    473       Calcium/calmodulin-dependent protein
FT                                kinase type IV.
FT                                /FTId=PRO_0000086106.
FT   DOMAIN       46    300       Protein kinase.
FT   NP_BIND      52     60       ATP (By similarity).
FT   REGION      301    340       Autoinhibitory domain.
FT   REGION      322    341       Calmodulin-binding (Potential).
FT   ACT_SITE    164    164       Proton acceptor (By similarity).
FT   BINDING      75     75       ATP (By similarity).
FT   MOD_RES      12     12       Phosphoserine; by autocatalysis.
FT   MOD_RES      13     13       Phosphoserine; by autocatalysis.
FT   MOD_RES     190    190       N6-acetyllysine.
FT   MOD_RES     200    200       Phosphothreonine.
FT   MOD_RES     336    336       Phosphoserine; by autocatalysis.
FT   MOD_RES     341    341       Phosphoserine.
FT   MOD_RES     356    356       Phosphoserine.
FT   MOD_RES     360    360       Phosphoserine.
FT   VARIANT     150    150       E -> G (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040604.
FT   VARIANT     178    178       D -> N (in dbSNP:rs35548075).
FT                                /FTId=VAR_040605.
FT   VARIANT     465    465       Q -> R (in dbSNP:rs56360861).
FT                                /FTId=VAR_040606.
FT   VARIANT     469    469       I -> M (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040607.
FT   MUTAGEN      12     12       S->A: Loss of activity.
FT   MUTAGEN      13     13       S->A: Loss of activity.
FT   MUTAGEN     320    321       FN->DD: Loss of interaction with
FT                                PPP2CA/PPP2CB.
FT   HELIX        42     44
FT   STRAND       46     51
FT   STRAND       58     65
FT   STRAND       71     78
FT   HELIX        93     95
FT   STRAND      104    109
FT   STRAND      111    118
FT   HELIX       126    130
FT   HELIX       138    157
FT   HELIX       167    169
FT   STRAND      170    176
FT   STRAND      181    183
FT   HELIX       210    213
FT   HELIX       221    226
FT   HELIX       230    235
FT   HELIX       248    255
FT   TURN        263    268
FT   HELIX       271    278
FT   HELIX       285    287
FT   HELIX       291    296
FT   TURN        298    300
FT   HELIX       311    335
SQ   SEQUENCE   473 AA;  51926 MW;  EFEE51E5612326DC CRC64;
     MLKVTVPSCS ASSCSSVTAS AAPGTASLVP DYWIDGSNRD ALSDFFEVES ELGRGATSIV
     YRCKQKGTQK PYALKVLKKT VDKKIVRTEI GVLLRLSHPN IIKLKEIFET PTEISLVLEL
     VTGGELFDRI VEKGYYSERD AADAVKQILE AVAYLHENGI VHRDLKPENL LYATPAPDAP
     LKIADFGLSK IVEHQVLMKT VCGTPGYCAP EILRGCAYGP EVDMWSVGII TYILLCGFEP
     FYDERGDQFM FRRILNCEYY FISPWWDEVS LNAKDLVRKL IVLDPKKRLT TFQALQHPWV
     TGKAANFVHM DTAQKKLQEF NARRKLKAAV KAVVASSRLG SASSSHGSIQ ESHKASRDPS
     PIQDGNEDMK AIPEGEKIQG DGAQAAVKGA QAELMKVQAL EKVKGADINA EEAPKMVPKA
     VEDGIKVADL ELEEGLAEEK LKTVEEAAAP REGQGSSAVG FEVPQQDVIL PEY
//
